A detailed history of Cassia Capital Partners, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Cassia Capital Partners, LLC holds 4,387 shares of ABBV stock, worth $770,269. This represents 0.57% of its overall portfolio holdings.

Number of Shares
4,387
Previous 4,635 5.35%
Holding current value
$770,269
Previous $794,000 9.07%
% of portfolio
0.57%
Previous 0.52%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

SELL
$163.84 - $199.33 $40,632 - $49,433
-248 Reduced 5.35%
4,387 $866,000
Q2 2024

Jul 19, 2024

BUY
$154.79 - $180.76 $13,776 - $16,087
89 Added 1.96%
4,635 $794,000
Q1 2024

Apr 22, 2024

BUY
$159.82 - $182.1 $139,842 - $159,337
875 Added 23.84%
4,546 $827,000
Q4 2023

Jan 29, 2024

BUY
$137.6 - $154.97 $17,200 - $19,371
125 Added 3.53%
3,671 $568,000
Q3 2023

Oct 16, 2023

BUY
$133.59 - $154.65 $9,885 - $11,444
74 Added 2.13%
3,546 $528,000
Q2 2023

Jul 20, 2023

BUY
$132.51 - $164.9 $180,478 - $224,593
1,362 Added 64.55%
3,472 $467,000
Q1 2023

Apr 21, 2023

SELL
$144.61 - $166.54 $6,796 - $7,827
-47 Reduced 2.18%
2,110 $336,000
Q4 2022

Jan 25, 2023

BUY
$138.31 - $165.87 $298,334 - $357,781
2,157 New
2,157 $0

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Cassia Capital Partners, LLC Portfolio

Follow Cassia Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cassia Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cassia Capital Partners, LLC with notifications on news.